The detection of prostate cells by the reverse transcription polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate

BJU International

Volumn 85, Issue 1, 2000, Pages 65-69

  Heung, Y M M ^a   Walsh, K ^a   Sriprasad, S ^a   Mulvin, D ^a   Sherwood, R A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Metastases; Polymerase chain reaction; Prostate specific antigen; Reverse transcription; Transurethral resection of the prostate

Indexed keywords

ETHIDIUM BROMIDE; MESSENGER RNA; PRIMER RNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0042983149     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00380.x     Document Type: Article

References (22)

1. 1 Catalona WJ. Management of carcinoma of the prostate. N Engl J Med 1994; 331: 996-1004
2. 2 Eisenstein BI. The polymerase chain reaction: a new method of using molecular genetics for medical diagnosis. N Engl J Med 1990; 322: 178-82
3. 3 Pelkey TJ, Frierson HF Jr, Bruns DE. Molecular and immunulogical detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996; 42: 1369-81
4. 4 Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996; 78: 10-6
5. 5 Deguchi T, Doi T, Ehara H et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993; 53: 5350-4
6. 6 Deguchi T, Yang M, Ehara H el al. Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. Br J Cancer 1997; 75: 634-8
7. 7 Moreno JG, Croce CM, Fischer R et al. Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res 1992; 53: 6110-2
8. 8 Gomella LG, Raj GV, Moreno JG. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 1997; 158: 326-37
9. 9 Katz AE, de Vries GB, Begg MD et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate-specific antigen as a true pathologic stage in patients with prostate cancer. Cancer 1995; 75: 1642-8
10. 10 Loric S, Dumas R, Eschwege P et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested RT-PCR assay based on prostate-specific membrane antigen. Clin Chem 1995; 41: 1698-704
11. 11 Israeli RS, Miller WH, Su SL et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994; 54: 6306-10
12. 12 Cama C, Olsson CA, Raffo AJ et al. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate-specific membrane antigen. J Urol 1995; 153: 1373-8
13. 13 Corey E, Arfman EW, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997; 43: 443-52
14. 14 Eschwege P, Dumas F, Blanchert P et al. Hematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995; 346: 1528-30
15. 15 Oefelein MG, Kaul KL, Herz B et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 1997; 155: 238-42
16. 16 Moreno JG, O'Hara M, Long JP et al. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology 1997; 49: 515-20
17. 17 Weiss L. Orr FW, Honn KV. Interactions of cancer cells with the microvasculature during metastasis. FASEB J 1988; 2: 12-21
18. 18 Katz AE, Olsson CA, Raffo AJ et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43: 765-75
19. 19 Ghossein RA, Scher HI, Gerald WL et al. Detection of circulating tumour cells in patients with localized and metastatic prostatic carcinoma: clinical applications. J Clin Oncol 1995; 13: 1195-200
20. 20 Olsson CA, de Vries GM, Begg MD et al. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J Urol 1996; 155: 1557-62
21. 21 Sokoloff MH, Tso CL, Kaboo R et al. Quantitative polymerase chain reaction assay does not improve prostate cancer staging: a clinical-pathologic-molecular analysis of 121 patients. J Urol 1996; 156: 1560-6
22. 22 Cama C, Olsson CA, Buttyan R et al. Molecular staging of prostate cancer III. effects of digital rectal exam, cytoscopy, and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction. J Urol 1996; 155: 553A